Project
Programme line Oncology
CMINEN will focus on breast, lung and prostate cancer. There are two major strategies that are likely to reduce cancer morbidity and mortality. The first is early detection, which will make curative treatment easier to apply, and the second is personalized (patient-tailored) tumor treatment.
Anatomical imaging techniques such as CT, MRI and mammography already play a role in cancer treatment, although that role is far from perfect. It is to be expected that the combination with molecular imaging techniques such as fluorescent imaging can support early detection with SPECT and PET scanning as well as facilitate the design of optimal radiotherapy and systemic treatment. Especially given that systemic treatment is increasingly directed at specific targets in the tumor, whole body SPECT and PET imaging combined with anatomical imaging can find those targets without resorting to invasive tumor biopsies. Biopsies are, in general, only available from one lesion, as lesions may be inaccessible and multiple biopsies are a serious burden on the patient. Combining imaging techniques can greatly enhance the role that imaging plays in oncology. In the coming years, long term results from the lung cancer screening study are expected (NELSON), as well as first results for new options for individualized breast cancer treatment (MAMMOTH, CTMM).
People
CMI Management
Molecular Imaging
Medical Imaging Informatics
Publications
No publications
Powered by: YTEC Imaging
